Tag: Servier

Servier buys oncology business from Shire

Shire, the leading global biotechnology company focused on rare diseases announced that it has entered into a definitive agreement with to sell its Oncology business for $2.4 billion.

ImmunoQure enters into exclusive partnership with Servier

ImmunoQure, a German biotech company, and the international pharmaceutical company Servier announced the establishment of an exclusive partnership for the development of a therapeutic autoantibody neutralizing interferon-alpha.

Servier upgrades its logistical capacity in Russia

Servier has officially launched its new logistical platform in Russia. It began to operate at the facilities of Santens Service Group

ViiV Healthcare localizes the manufacturing of dolutegravir in Russia

viiv healthcare
Three registration lots of dolutegravir manufactured at Servier Pharmaceutical Plant in Russia successfully passed stability tests and comparative dissolution kinetics tests

Servier launches a new high-tech facility in Russia

As part of events held to mark the 10th anniversary of its pharmaceutical plant in Russia, Servier launched a new high-tech process to manufacture the medicinal products.

Servier and CTI BioPharma extended their collaboration

Servier and CTI BioPharma Corp. jointly announced that they agreed to expand their existing license and development collaboration agreement for PIXUVRI (pixantrone). Under this expanded agreemen...

Servier will manufacture an oral anticoagulant in Russia

Servier JSC and Daiichi Sankyo Europe have signed a strategic license agreement under which Servier JSC received the rights to manufacture/package edoxaban, an oral anticoagulant, at its pharmaceutica...